6849.T Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (2 geg. 2024 @ 09:15):

Stats
Šios dienos apimtis	89 800.00
Vidutinė apimtis	236 755
Rinkos kapitalizacija	365.62B
EPS	¥0 ( 2024-02-01 )
Kita pelno data	( ¥87.32 ) 2024-05-12
Last Dividend	¥41.00 ( 2023-03-30 )
Next Dividend	¥0 ( N/A )
P/E	22.61
ATR14	¥2.67 (0.06%)

Tūris Koreliacija

Ilgas: -0.02 (neutral)

Trumpas: -0.20 (neutral)

Signal:(33.906) Neutral

Nihon Kohden Corporation Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Nihon Kohden Corporation Koreliacija - Valiuta/Žaliavos

0.79
( moderate )

0.82
( strong )

0.09
( neutral )

0.88
( strong )

-0.76
( moderate negative )

-0.92
( very strong negative )

Nihon Kohden Corporation Finansinės ataskaitos

Annual	2022
Pajamos:	¥206.60B
Bruto pelnas:	¥105.93B (51.27 %)
EPS:	¥203.28

FY	2022
Pajamos:	¥206.60B
Bruto pelnas:	¥105.93B (51.27 %)
EPS:	¥203.28

FY	2022
Pajamos:	¥205.13B
Bruto pelnas:	¥109.09B (53.18 %)
EPS:	¥276.51

FY	2021
Pajamos:	¥199.73B
Bruto pelnas:	¥102.23B (51.19 %)
EPS:	¥214.21

Financial Reports:

No articles found.

Nihon Kohden Corporation Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
¥20.00 (N/A)	¥0 (N/A)	¥41.00 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)

Nihon Kohden Corporation Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.63 - Stable (12.63%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	¥1.250	2001-03-27
Last Dividend	¥41.00	2023-03-30
Next Dividend	¥0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	46	--
Total Paid Out	¥558.75	--
Avg. Dividend % Per Year	0.00%	--
Score	3.99	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	5.63
Div. Directional Score	8.44	--

Next Divdend (Est)
(2024-07-03)

¥0 Estimate 1.26 %

Dividend Stability

0.10 Bad

Dividend Score

3.99

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for JPX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
7915.T	Ex Dividend Junior	2023-12-28	Semi-Annually	0.00%
7102.T	Ex Dividend Junior	2023-09-28	Annually	0.00%
6381.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
5331.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
4373.T	Ex Dividend Knight	2024-03-28	Annually	0.00%
3543.T	Ex Dividend Knight	2024-02-28	Semi-Annually	0.00%
2768.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
9663.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
8624.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
8194.T	Ex Dividend Knight	2024-02-28	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0741	1.500	8.52	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0750	1.200	7.50	9.00	[0 - 0.3]
returnOnEquityTTM	0.0947	1.500	-0.0584	-0.0877	[0.1 - 1]
payoutRatioTTM	0.369	-1.000	6.31	-6.31	[0 - 1]
currentRatioTTM	4.03	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	2.43	0.800	0.425	0.340	[0.8 - 2.5]
cashRatioTTM	0.769	1.500	6.84	10.00	[0.2 - 2]
debtRatioTTM	0.00205	-1.500	9.97	-10.00	[0 - 0.6]
interestCoverageTTM	1 558.31	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	168.66	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	71.40	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0.00258	-1.500	9.99	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.507	1.000	4.88	4.88	[0.2 - 0.8]
operatingProfitMarginTTM	0.0928	1.000	-0.143	-0.143	[0.1 - 0.6]
cashFlowToDebtRatioTTM	32.11	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	1.011	0.800	6.59	5.27	[0.5 - 2]
Total Score				11.26

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	22.58	1.000	7.82	0	[1 - 100]
returnOnEquityTTM	0.0947	2.50	-0.0376	-0.0877	[0.1 - 1.5]
freeCashFlowPerShareTTM	71.40	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	1.406	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	168.66	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0.369	1.500	6.31	-6.31	[0 - 1]
pegRatioTTM	0.776	1.500	8.16	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0650	1.000	-0.874	0	[0.1 - 0.5]
Total Score				5.63

Nihon Kohden Corporation

Nihon Kohden Corporation engages in research and development, production, sale, repair, and maintenance of medical electronic equipment in Japan, Americas, Europe, rest of Asia, and internationally. The company offers physiological measuring equipment, including electroencephalographs, electrocardiographs, evoked potential and electromyogram measuring instruments, and polygraphs for cath labs, as well as diagnostic information systems and related consumables, such as recording papers, electrodes and catheters, and maintenance services. It also provides patient monitors systems comprising central monitors, bedside monitors, wireless monitors, remote access software, and other equipment; and clinical information systems and related consumables, such as electrodes and sensors. In addition, the company offers treatment equipment, which include defibrillators, automated external defibrillators (AED), ventilators, pacemakers, anesthesia machines, cochlear implants, and related consumables and services, which include AED pads and batteries; and other medical equipment, including hematology and clinical chemistry analyzers, ultrasound diagnostic equipment, and equipment for research and others, as well as consumables, including test reagents, and installation and maintenance services. Additionally, it engages in insurance brokerage and technology licensing business. The company was incorporated in 1951 and is headquartered in Tokyo, Japan.